# AXIM BIOTECHNOLOGIES, INC.

AXIM BIOTECHNOLOGIES, INC. is a public company listed on OTC as AXIM, headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** AXIM BIOTECHNOLOGIES, INC.
- **Former names in filing history:** AXIM INTERNATIONAL INC. (2011-03-10 to 2014-08-13)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **Ticker:** OTC: AXIM
- **SEC CIK:** 0001514946

## About

AXIM BIOTECHNOLOGIES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001514946, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-04-16, it reported annual revenue of USD 39,518; net income of USD -8,059,682; total assets of USD 4,121,548 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $39,518 (USD 39,518)
- **Net income:** -$8.1M (USD -8,059,682)
- **Total assets:** $4.1M (USD 4,121,548)
- **Operating cash flow:** -$1.0M (USD -1,030,500)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $8,875 (USD 8,875)
- **Net income:** -$6.2M (USD -6,242,949)
- **Total assets:** $4.2M (USD 4,212,035)
- **Cash and equivalents:** $47,282 (USD 47,282)
- **Operating cash flow:** -$2.0M (USD -2,044,326)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $60,460 (USD 60,460)
- **Net income:** -$16.0M (USD -16,032,305)
- **Total assets:** $5.3M (USD 5,323,435)
- **Cash and equivalents:** $452,963 (USD 452,963)
- **Operating cash flow:** -$2.5M (USD -2,486,765)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$6.4M (USD -6,409,880)
- **Total assets:** $11.3M (USD 11,314,395)
- **Cash and equivalents:** $457,181 (USD 457,181)
- **Operating cash flow:** -$3.2M (USD -3,215,699)

## Recent SEC filings

- Form 8-K — filed 2024-10-15 — period 2024-10-09 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
- Form 10-Q — filed 2024-08-19 — period 2024-06-30 — FORM 10-Q
- Form 10-Q — filed 2024-05-20 — period 2024-03-31 — FORM 10-Q
- Form 10-K — filed 2024-04-16 — period 2023-12-31 — FORM 10-K
- Form 8-K — filed 2024-03-21 — period 2024-03-15 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
- Form 8-K — filed 2024-02-13 — period 2024-02-07 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
- Form 8-K — filed 2023-12-28 — period 2023-12-26 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
- Form 10-Q — filed 2023-11-20 — period 2023-09-30 — FORM 10-Q
- Form 10-Q — filed 2023-08-21 — period 2023-06-30 — AXIM BIOTECHNOLOGIES FORM 10-Q
- Form S-1 — filed 2023-06-02 — FORM S-1
- Form 8-K — filed 2023-06-02 — period 2023-06-01 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
- Form 8-K — filed 2023-05-30 — period 2023-05-23 — AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/axim-biotechnologies-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology